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Immune responseImmunopathology during early simian retrovirus type 2 (SRV-2) infection is poorly characterized. Here, viral
dynamics, immune response and disease progression in transiently- or persistently-infected cynomolgus
macaques are assessed. Viral nucleic acids were detected in selected lymphoid tissues of both persistently-
and transiently-infected macaques, even after viral clearance from the periphery. Immunohistochemical
staining of lymphoid tissues revealed alterations in a number of immune cell populations in both transiently-
and persistently-infected macaques. The precise pattern depended upon the infection status of the macaque
and the marker studied. Gross immunopathological changes in lymphoid tissues were similar between SRV
infection and those observed for other simian retroviruses SIV and STLV, suggesting a common
immunopathological response to infection with these agents.Mitchell).
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Simian retroviruses (SRV) are exogenous Betaretroviruses found
naturally in both New World and Old World monkeys. These viruses
have been reported to cause signiﬁcant morbidity, mortality and
immunosuppression in macaques (Grant et al., 1995; Lerche et al.,
1989). SRV-1 and SRV-2 have been shown to be the primary causative
agents of an immunosuppressive AIDS-like disease in macaques
(SAIDS) which may be transmitted both vertically and horizontally.
Unlike experimental infection of macaques with simian immunode-
ﬁciency virus (SIV), SRV can produce a spectrum of clinical outcomes
and only in its most severe form causes a disease almost indistin-
guishable from that caused by SIV (Montiel, 2010; Wilkinson et al.,
2003). Somemacaques eradicate virus, evident by the failure to detect
virus in secretions, plasma and peripheral blood. Some macaques
become persistently infected and survive with low level viremia,
while others are asymptomatic carriers, producing anti-SRV speciﬁc
antibodies which are temporally associated with a decline in viremia
(Lerche et al., 1986; Marx et al., 1984; Maul et al., 1986; Wilkinson
et al., 2003).
To understand the factors that determine the ultimate outcome of
infection, it is important to characterize early virus-host interactions.
Currently, little is known about the viral dynamics, bio-distribution
and host immune response during early infection. These events arecritical since fatal or persistent disease has been associated with
lymphadenopathy, splenomegaly, fever, diarrhea, anemia, weight
loss, opportunistic infections, noma and a ﬁbroproliferative syndrome
(Antman and Chang, 2000; Heidecker et al., 1987; Marx and
Lowenstine, 1987; Maul et al., 1986; Philipp-Staheli et al., 2006; Tsai
et al., 1986). Nevertheless, SRV-2 infection can be very effectively
controlled by the production of neutralizing antibodies.
We have previously reported on the mechanisms of virus–host
interaction that may affect transmission of SRV-2 and control of
viremia in the early stages of infection (Wilkinson et al., 2003). We
demonstrated that experimental inoculation of cynomolgus maca-
ques with SRV-2 does not necessarily result in a productive infection.
While an antibody response may contribute to eventual clearance of
virus, preceding events at the cellular level are likely important in
inﬂuencing control of early infection and disease outcome.
To better understand the association between these events and an
ability to naturally clear SRV-2 infection, we compare early immuno-
pathology and viral burden in key immune organs of transiently- and
persistently-infected macaques, prior to the onset of SAIDS, using
molecular and histological approaches. SRV-2 distribution and
loads were analyzed by in situ hybridization (ISH) and quantitative
PCR (q-PCR) respectively. The frequency and levels of selected
immune cell marker expression in mesenteric lymph nodes (MLN)
and spleen were investigated by immunohistochemical analyses of
formalin-ﬁxed tissues collected at necropsy. The data highlight that
persisting alterations may occur in lymphoid tissues following the
clearance of virus from the periphery due to the presence of low levels
of SRV-2 sequestered in these tissues. The histopathological changes
observed are reminiscent of those reported after persisting infection
162 J.L. Mitchell et al. / Virology 413 (2011) 161–168with other simian retroviruses that infect immune cells, suggesting
that there may be common immunopathological processes occurring
in all these infections in the absence of effective viral control.
Results
Detection of SRV-2 nucleic acid in the MLN and spleen
SRV-2 proviral DNA loads within the MLN and spleen of
persistently-infected macaques were quantiﬁed by PCR. Proviral
DNA was detected in persistently-infected macaques (Table 1; 977G
and 176ABA) with the loads higher in 977G than 176ABA. Proviral
DNA was not detected in the lymphoid tissue of transiently-infected
(Table 1; X382 and X383) or uninfected (Table 1; 958EH and M955C)
macaques.
Digoxigenin (DIG)-incorporated ISH probes were shown to be
speciﬁc for SRV-2 RNA (Figs. 1A and B; SRV-2 DNA probe after
pretreatment with RNase, data not shown). SRV-2 RNA was detected
in both the spleen and the MLN of the two persistently-infected
macaques (Figs. 1A and C). RNA was located predominately in the
paracortex and red pulp, with only diffuse staining seen in the follicles
and white pulp regions. The frequency of ISH positive cells was higher
in both tissues from 977G compared with tissues from 176ABA. The
higher frequency was most notable in the paracortex of the MLN with
approximately 60% more staining seen in 977G than in 176ABA (data
not shown).
Viral RNA was detected in the spleen of transiently-infected
macaques (Fig. 1E). ISH probes bound to cells located in the red pulp
regions with only scattered staining throughout the white pulp. The
frequency of ISH positive cells in the spleen of transiently-infected
macaques was lower than that seen in persistently-infected maca-
ques, within both the white pulp germinal centers and the red pulp
region (Fig. 1E). Viral RNAwas not detected in the MLN of transiently-
infected macaques (Fig. 1G) nor in the MLN or the spleen of
uninfected macaques (data not shown).
Degeneration of the germinal follicles in the spleen of
persistently-infected animals
Histological differences were seen in the spleen of persistently-
infected macaques by H&E staining (Fig. 2). The morphology of the
red pulp and white pulp regions of the spleen appeared consistent
throughout the tissue, with well-deﬁned follicular regions for both
transiently-infected (X382 and X383; data not shown) and uninfected
macaques (958EH and M955C; Figs. 2A and B). By contrast,
morphological disorganization of the red pulp and white pulp regions
was observed in persistently-infected macaques (977G and 176ABA;
Figs. 2C and D) but not in transiently-infected and uninfectedTable 1
Shows the six macaques selected for the study, their age at euthanasia, age at infection, infe
response and viral copies present.
Infection status*




VI LTR Ab Dura
infec
977G 2.3 ND Persistent + +~ + 2 yea
176ABA 13.9 ND Persistent ND +~ + 4 yea
X382 2.2 1.7 Transient +14day − +14day 14 da
X383 2.0 1.5 Transient +14day − +14day 14 da
958EH 1.7 N/A Negative ND − − N/A
M955C 0.5 N/A Negative ND − − N/A
*Method used to determine infection status; + — positive for the assay, +~ — positive at thr
for the assay. Assay types; VI — virus isolation, LTR — LTR-PCR Assay, Ab — SRV-2 Ab asses
**SRV-2 positive antibody response (log10), low — never exceeds 2.4, moderate — N2.4 b3.
***Viral copies in approximately 15,000 cells.
ND — not determined, N/A — not applicable.macaques (Figs. 2A and B). This was noticeable in the red pulp region
by loss of cellular organization of the splenic cords and sinuses
(Fig. 2C, dashed arrow) and in the white pulp regions by follicular
enlargement (follicular hyperplasia) when comparing follicles ob-
served in 958EH and 977G (Figs. 2A and C), with loss of normal tissue
architecture in themarginal andmantle zones and an accumulation of
proteinaceous deposits within the germinal centers (Fig. 2D, solid
arrow). The disordered cellular organization of the spleen in the
persistently-infected macaques was most apparent in 977G which
exhibited a greater degree of follicular enlargement, proteinaceous
deposits and general disorganization of both the white pulp and red
pulp regions than seen in 176ABA. Nodular follicular hyperplasia was
evident in the MLN of 176ABA only (data not shown).
Immunopathological changes in the MLN and spleen of
persistently-infected macaques
The frequency and intensity of staining for T- and B-lymphocytes,
macrophages and antigen presenting cells (APC) in the MLN were
determined for all macaques by IHC. Representative data from
persistently- (977G), transiently- (X283) and uninfected (958EH)
macaques are presented in Fig. 3. The breadth and intensity of staining
were assessed according to the scoring indices in footnotes of Table 2.
An overall cumulative staining value was generated as the product of
the individual breadth and intensity staining scores (Table 2). Lower
levels of T lymphocytes, B lymphocytes, macrophages and APC were
detected in the MLN of persistently-infected macaques (977G and
176ABA), than in the MLN from transiently-infected macaques (X382
and X383). Levels of staining for T lymphocytes and macrophages
were observed in the MLN of both the transiently-infected macaques
(X382 and X383) were comparable with those in the uninfected
macaques (958EH and M955C). The level of B lymphocyte staining
was comparable between uninfected and persistently-infected maca-
ques, while the levels of staining for APC in persistently-infected
macaques were lower than in both uninfected and transiently-
infected macaques.
The frequency and intensity of staining for T and B lymphocytes,
macrophages and APC were likewise determined in the spleen
(Table 2). Representative data from persistently- (977G), transiently-
(X283) and uninfected (958EH) macaques are presented in Fig. 4.
Elevated levels of T and B lymphocytes and macrophages were
observed in the spleen of persistently-infected macaques (977G and
176ABA), compared with transiently-infected (X382 and X383) and
uninfected macaques (958EH and M955C). Similar responses were
seen in uninfected and transiently-infected macaques for all immune
markers assessed. Comparable levels of APC were observed in all
macaques (data not shown). The locations of staining for macro-














rs N/A Low N/A 30 115 196
rs N/A None N/A 27 1 55
ys 228 days Strong + 0 0 0
ys 228 days Strong + 0 0 0
N/A None N/A 0 0 0
N/A None N/A 0 0 0
ee time point before euthanasia, +14day — positive 14 days post infection,− — negative
sed by enzyme linked immunosorbent assay.
0, strong — N3.0.
Fig. 1. In situ hybridization of spleen and MLN sections from 977G hybridized with SRV-2 DNA probe (A, C) and without SRV-2 DNA probe (B, D). SRV-2 mRNA positive cells are
visualized by blue precipitate. Spleen and MLN sections from X382 hybridized with SRV-2 DNA probe (E, G) and without DNA probe (F, H). Magniﬁcation 200×.
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lymphocytes were detected in the marginal and mantle zones of the
white pulp rather than the germinal centers, and T lymphocytes were
found in the germinal centers rather than the red pulp, marginal and
mantle zones (Fig. 4).
Discussion
The outcomes of chronic viral infections are frequently deter-
mined by early viral–host interactions that precede clinical symptoms
by many months or years. We assessed and compared the immuno-
pathology inmacaques infected persistently or transiently with SRV-2,
in order to identify factors or events that determine clinical prognosis.
We focused our study on two key immune organs, the MLN and the
spleen, and compared proviral DNA and viral RNA levels.Proviral DNA and viral RNA were detected in the spleen and MLN
of persistently-infected macaques, while viral RNA but not proviral
DNA was detected in the spleen of transiently-infected macaques.
Viral RNA was detected primarily in the red pulp regions, around the
follicles and paracortex. This distribution is consistent with observa-
tions from reports of SRV-associated SAIDS and infection of other
retroviruses. In SRV-associated SAIDS and SIV infection, viral RNA is
detected in the paracortex and red pulp regions (Canto-Nogues et al.,
2001; Reinhart et al., 1997; Zhang et al., 2007) while in HTLV-1
infection viral RNA accumulates around the germinal centers and next
to the capillaries (Kazanji et al., 2000). While it was expected that
proviral DNA and viral RNA would be detectable in the spleen of the
persistently-infected macaques, the detection of viral RNA in the
spleen of transiently-infected macaques was unexpected as it had
been many months since the clearance of detectable proviral DNA in
Fig. 2. Haematoxylin and eosin (H&E) staining of spleen sections from persistently-infected and uninfected macaques. Spleen sections from uninfected macaques 958EH (A, B) and
from persistently-infectedmacaques 977G (C, D). Red pulp (RP), white pulp (WP). Loss of tissue architecture is evident with disruption of the splenic cords and sinuses (indicated by
the dashed arrow), accumulations of proteinacous material (indicated by a solid arrow). Magniﬁcation 40×, 100×.
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collected at necropsy (Wilkinson et al., 2003).
The detection of SRV by ISH in the spleen of otherwise
“transiently” infected macaques, highlights a feature of this retrovirus
that has implications for screening assays used to establish the SRV
status of groups of macaques. In previous studies, we had demon-
strated that some macaques with a persistent high viremia and most
likely to transmit infection, were frequently anti-SRV seronegative
(Wilkinson et al., 2003). In that situation, a DNA PCR was more
valuable than serology (Wilkinson et al., 2003) and was subsequently
used to apparently eliminate SRV-2 from a closed colony of
cynomolgus macaques (Mee et al., 2009). This approach corroborated
data published from studies in other breeding groups in attaining
SRV-free colonies (Hara et al., 2005; Lerche et al., 1991, 1994;
Yasutomi, 2010). The data presented here further highlight that SRV-2,
like most retroviruses, is extremely difﬁcult to eliminate completely
and macaques that exhibit transient viremia may harbor a small
number of infected cells in selected lymphoid tissues that express viral
RNA.
To characterize the impact of SRV infection on the host, we
compared the histopathology of spleen and MLN from macaques that
had exhibited transient or persistent viremia. No histopathological
changes were observed in the tissue from the macaques that had
exhibited transient viremia, whereas enlargement of the follicles
(hyperplasia) and disorganization of the red pulp region involving
loss of the normal arrangement of the splenic cords and venous
sinuses were observed in the spleens of persistently-infected
macaques. Furthermore, deposits of protein, likely to be an accumu-
lation of amyloid (Chalifoux et al., 1984; McGinn et al., 2002; Pallesen
et al., 1987), were observed in splenic follicles. These histopatholog-
ical changes within the spleen were more pronounced in 977G, whichexhibited a higher proviral DNA burden and a higher frequency of ISH
positive cells. However, histopathological changes within the MLN
were only observed in 176ABA, which may reﬂect the extended
duration of infection in this macaque.
These histopathological changes (follicular hyperplasia with
hyalinized germinal centers) have been reported previously in
immunodeﬁciency disease, while follicular fragmentation or disrup-
tion and amyloid deposited around vessels have been observed in the
lymph nodes of macaques infected with STLV (Chalifoux et al., 1984;
Guzman et al., 1999; McGinn et al., 2002; Meyer et al., 1985; Pallesen
et al., 1987; Zhang et al., 2007). These changes have been proposed to
contribute to the increasing immune dysfunction and a decrease in
the ability of the host immune system to process antigen and respond
to viral infection (Szakal et al., 1989). In previous reports describing
these histopathological changes the tissues analyzed were from
macaques that had exhibited overt clinical symptoms of immunode-
ﬁciency. Our ﬁndings demonstrate that these changes occur prior to
the development of the clinical syndrome. Nevertheless it would be
anticipated that if left the macaques exhibiting persistent viremia and
these histopathological changes would succumb to SRV-induced
SAIDS.
Since the publication of many of the original reports of the histo-
pathological changes associated with SRV-induced disease, improved
techniques and reagents have been developed to dissect the immu-
nopathology of SRV infection. Using immunological reagents to
distinguish lymphocytes (CD3), B cells (CD20), macrophages (CD68)
and follicular dendritic cells (S100) in macaque lymphoid tissues, we
were able to identify very different changes in the spleen and MLN of
macaques exhibiting transient and persistent viremia. Elevated B cell
and antigen presenting cell frequencies were observed in the MLN of
macaques exhibiting transient viremia, compared with uninfected
Fig. 3. Immunostaining on MLN sections from persistently-infected, transiently-infected and uninfected-macaques. CD3 staining (A, B, C), CD20 staining (D, E, F), CD68 staining
(G, H, I), S100 staining (J, K, L). Magniﬁcation 100×.
165J.L. Mitchell et al. / Virology 413 (2011) 161–168individuals. By contrast, there was a marked reduction of T cells, B
cells, macrophages and APC in the same tissues recovered from
persistently-infected macaques. Whether this evidence of immune
dysfunction contributed to the undetectable serum anti-SRV-2
antibody response reported in these macaques (Wilkinson et al.,
2003) is not certain, since the failure to control the viremia would be
expected to contribute to the developing immune dysfunction.
Changes in major immune cell populations were also evident in
the spleen, but these appeared to be the opposite of those observed in
the MLN. Elevated T cells, B cells and macrophages were noted in the
spleen of the persistently-infected macaques compared with tran-
siently- and uninfected macaques. Notably, the location of speciﬁcally
stained cells was unexpected: T cells were detected in the germinal
centers and B cells populated the marginal and mantle zones of thewhite pulp and were also scattered through the red pulp. While the
elevated macrophage levels may reﬂect their role in removing cells
affected by the virus and not be directly related to immune response,
the results of T and B cell immune-staining clearly support evidence of
immune hyper-activation.
Reports on early changes seen in the lymph nodes of man and
macaques suffering from immunodeﬁciency disease corroborate our
ﬁndings: proliferating T cells are seen in the interfollicular region and
B cells, no longer conﬁned to the parafollicular areas, are seen in both
the B cell and surrounding T cell areas (Chalifoux et al., 1984; Meyer
et al., 1985). Similarly, SIV-infected macaques which rapidly progress
to disease have severe depletion of proliferating B cells from the
germinal centers, manifesting as a dysfunction of B cell immunity
(Zhang et al., 2007). These differences in the immune cell population
Table 2
Staining breadth and staining intensity obtained for each immune marker assessed in
the MLN and the spleen of the six macaques.
Tissue Animal
ID
CD3 CD20 CD68 S100
B* I** C*** B I C B I C B I C
MLN 977G 2 2 4 2 2 4 1 2 3 1 1 2
176ABA 3 2 5 2 2 4 1 1 2 1 1 2
X382 3 3 6 3 3 6 2 2 4 2 2 4
X383 3 3 6 3 2 5 2 2 4 2 2 4
958EH 3 3 6 2 2 4 2 2 4 2 1 3
M955C 3 2 5 2 1 3 2 2 4 2 1 3
Spleen 977G 2 3 5 3 3 6 1 1 2 2 2 4
176ABA 3 3 6 3 2 5 1 1 2 2 2 4
X382 2 1 3 2 2 4 0.5 0.5 1 2 2 4
X383 2 1 3 2 2 4 0.5 0.5 1 2 2 4
958EH 2 1 3 2 2 4 0.5 0.5 1 2 2 4
M955C 2 1 3 2 2 4 0.5 0.5 1 2 2 4
B⁎; Breadth of staining, % of cells which stain; 0 — 0% none, 0.5 — 0–4% occasional, 15–
25% low, 2 — 26–74% moderate, 3 — N75% high.
I⁎⁎; Intensity of staining, 0 — none, 0.5 — low, 1 — weak, 2 — moderate, 3 — strong.
C⁎⁎⁎; Cumulative score, breadth+intensity.
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corroborate data from macaques suffering from SAIDS and once again
indicate that immunopathology originally described as being associ-Fig. 4. Immunostaining on spleen sections from persistently-infected, transiently-infected a
(G, H, I). B lymphocytes in the marginal and mantle zone of the white pulp follicles (solid arro
(dashed arrow). Magniﬁcation 100×.atedwith overt clinical diseasemay indeed develop at an earlier stage.
Further work is needed to establish whether these early signs are
associated as a cause or effect of disease pathogenesis.
Previously, we demonstrated that blood from a persistently-
infected macaque could result in infection in a naïve recipient
(Wilkinson et al., 2003). Here our data show that macaques that
exhibited transient viremia still harbor SRV-2 in selected lymphoid
tissues 228 days post infection. Intriguingly no histopathological
changes were apparent in these lymphoid tissues, however, the more
discriminatory immunohistochemical analysis of these tissues indicates
that more subtle alterations have taken place and activation of a
number of immune cell populations has occurred in the MLN.
Understanding whether these changes contribute to the effective
control of SRV-2 by the host or represent an early step in the failure to
prevent disease is uncertain and would require study of further
macaques at various stages of retroviral infection. From the viewpoint
of managing retroviral infection in colonies of macaques the similarities
between the immunopathology of early SRV-2 infection and that of
other retroviruses such as SIV and STLV, may contribute to our
understanding how concurrent retroviral infections interact inﬂuenc-
ing the overall disease outcome. By studying macaques infected with
more than one of these viruses, we will be able to investigate the
relative contribution of each virus to the onset, and potential
modiﬁcation, of the ﬁnal disease outcome in any particular individual.nd uninfected-macaques. CD3 staining (A, B, C), CD20 staining (D, E, F), CD68 staining
w) and T lymphocytes in the germinal centers (GC) and the marginal and mantle zones
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Animal samples
MLN and spleen tissue were available from six purpose-bred
cynomolgus macaques (Macaca fasicularis): three from a previous
study (X382, X383, and 977G; (Wilkinson et al., 2003) and three
macaques selected on the basis of SRV infection status, 958EH, M955C
and 176ABA (Table 1). All macaques were housed and maintained in
accordance with the United Kingdom Home Ofﬁce guidelines for the
care and maintenance of non-human primates. Of the six macaques;
two were uninfected (958EH and M955C), two were persistently-
infected (977G and 176ABA) and twowere transiently-infected (X382
and X383). The persistently-infected macaques were naturally
infected and known to be viremic for at least two years prior to this
study, while the transiently-infected macaques had been initially
identiﬁed as naïve for SRV-2 then inoculated intravenously with 1 ml
of whole blood from macaque 977G. These transiently-infected
macaques were shown to be viremic at the ﬁrst 14 days only of the
228 day study ((Wilkinson et al., 2003); Table 1). None of the
macaques showed clinical signs of disease at termination and tissues
obtained from each macaque were formalin-ﬁxed and parafﬁn-
embedded. Sections (4 μm) of each tissue were cut and mounted
onto glass slides. Prior to any treatment all slides were de-parafﬁnized
using xylene (Fisher Scientiﬁc UK Ltd, Leicestershire UK) and re-
hydrated using an ethanol series.
Viral load quantiﬁcation
Quantiﬁcation of the SRV-2 genome by real time PCR was
performed using the Mx3000P PCR System (Stratagene, California
USA). Primers and probe were designed against the LTR-PBS region of
SRV-2 (GenBank accession number M16605) using the parameters
deﬁned by Primer Express™ software version 2.0 ABI (Applied
Biosystems, California USA). The primers and probe were: forward
primer QSRV2-F308 (nt 308–330), 5′ CAT CCA GGT TCT ACG TTG CTG
AT 3′; reverse primer QSRV2-R446 (nt 426–446), 5′ GGC AGC TGG
AAG GTT TTT CTT 3′; probe QSRV2-P347 (nt 347–364), 5′ 6FAM CGT
GGC GCC CAA CGT GGG 3′ BHQ1 (Euroﬁns MWG Operon, Ebersberg
Germany).
A region of SRV-2 (nt 21–1122, GenBank accession number
M16605) was cloned into pGEM®-T vector (Promega UK Ltd,
Southampton Hampshire) creating pGEM-SRV2 to be used as a PCR
positive control for PCR ampliﬁcation. Duplicate ampliﬁcation reac-
tions were performed in a 96-well plate using DNA (100 ng/μl) from
MLN, spleen and the control plasmid (in a 10-fold dilution series
ranging from 4.25×106 copies/μl to 4.25×10−1 copies/μl), in a 25 μl
reaction volume containing; 1×Taqman universal PCR master mix
(Applied Biosystems), 600nM QSRV2-F308, 400nM QSRV2-R446 and
400nMQSRV2-P347. DNA ampliﬁcation comprised 1 cycle at 95 °C for
10 min, followed by 45 cycles of 95 °C for 30 s and 60 °C for 1 min. The
mean viral copy number was determined by reference to the standard
curve generated from the plasmid dilutions.
Detection of cellular proteins by immunohistochemistry (IHC)
Tissue sections were de-parafﬁnized and re-hydrated and IHC was
performed in the Omnislide hybridization system (Thermo-Hybaid,
Middlesex UK). To identify major immune cell populations, tissue
sectionswere treatedwith polyclonal rabbit anti-human CD3 (A0452)
to detect broadly reactive T cells, polyclonal rabbit anti-human S100
(Z0311) to detect antigen presenting cells, monoclonal mouse anti-
human CD20cy Clone L26 (M0755) to detect naïve B cells, or
monoclonal mouse anti-human CD68 Clone KP1 (M0814) antibodies
to detect macrophage cells (Dako UK Ltd, Ely UK). These antibodies
were chosen as they were shown to be cross-reactive to simianproteins and biotinylated universal anti-mouse/rabbit secondary
antibody (Vector Laboratories, Peterborough UK) was used with the
chromagenic substrate 3,3′-di-aminobenzidine tetrahydrochloride for
detection as previously reported (Ferguson et al., 2007).
Analysis of IHC
Each tissue section was visualized using a microscope (Nikon
Eclipse E400) on a 40× magniﬁcation using the Metaview software
(Meta Imaging software—MDS Analytical Technologies Ltd, Berkshire
UK) and images were captured using a Nikon CoolSNAP camera. A
scoring index (adapted from Bukholm et al., 2003; Canto-Nogues
et al., 2001) for the breadth of staining present (percentage of cells
that stained) and intensity of the staining was used (Table 2; see
footnotes). Five ﬁelds of view were evaluated and an average scoring
index derived.
Detection of SRV RNA by in situ hybridization (ISH)
Preparation of DNA probes
Double-stranded digoxigenin-labeled DNA probes were prepared
using DNA ampliﬁcation. Three pairs of oligonucleotide primers were
used to amplify regions of the SRV-2 genome: LTR-gag, SRV-2 pol,
SRV-2 env sequences which had been cloned into the pGEM®-T
vector. Primers were designed as before. DLTR499N (nt 102–126),
5′ TTT CCC GCC GGC GCG AAT ATT TCC 3′; DBPS775C (nt 358–380),
5′ TTC CCT CGT ATC CAG CCC CAC GTT 3′, SRV2POL3788N (nt 3788–
3808), 5′ AAT AGC AGG AAA ACT TGG CGA 3′; SRV2POL4138C
(nt 4119–4138) , 5′ CAG CCC TTG CGT CTC TTC A 3′), SRV2ENV5721N
(nt 5901–6008), 5′ GCA CCT ACA GTC TAT CTT 3′; SRV2ENV6071C
(nt 6246–6264), 5′ ATG TCC CCA CAG TTT TGG 3′), where nucleotide
numbers refer to SRV-2 sequenceGenBank accessionnumberM16605.
DNA (60 ng) was ampliﬁed in a 50 μl reaction volume comprising
10 mM Tris–HCl, pH 8.3; 50 mM KCl; 3 mM MgCl2, 1.25 U AmpliTaq
Gold DNA polymerase (Applied Biosystems) and a Dig-dNTP mix
(1 mM each of dATP, dCTP, dGTP, 0.3 mM dTTP, 0.1 mM digoxigenin-
labeled dUTP; Roche Diagnostics Ltd). Ampliﬁcation of all three
regions comprised a single cycle at 94 °C for 10 min, followed by 40
cycles comprising 94 °C for 1 min, 55 °C for 2 min and 72 °C for 3 min,
and a ﬁnal incubation at 72 °C for 10 min. DNA ampliﬁcation was
performed in a T3 thermal cycler (Hybaid, Teddington UK). In-
corporation of the digoxigenin-labeled dUTPwas assessed using a DIG
nucleic acid detection kit (Roche Diagnostics Ltd) according to the
manufacturer's instructions.
In situ hybridization (ISH)
Tissue sections were de-parafﬁnized and re-hydrated as for IHC.
All ISH incubation steps were performed in the Omnislide hybridiza-
tion system (Thermo-Hybaid, Middlesex UK). The in situ hybridization
protocol was then performed using the digoxigenin-labeled SRV-2
probes (Auda et al., 1998). To conﬁrm the speciﬁcity of the DNA probe
for detection of SRV-2 RNA, the probe was applied to tissue from an
infected animal with or without prior tissue treatment with 20 μg/ml
RNase A solution (Qiagen, Sussex UK).
Analysis of ISH
The breadth of staining for each sectionwas evaluated as described
for IHC.
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